Search results
Merck & Co Inc (MRK) Sits And Waits For Direction At $131.30 Price – Stocks Register
Stocks Register· 5 days agoMerck & Co Inc (NYSE:MRK) at last check was buoying at $131.30 on Thursday, May 23 with a rise of 0.15% from its closing price on previous day. Taking a look at stock we notice ...
Merck’s MilliporeSigma agrees to acquire Mirus Bio for $600m
Pharmaceutical Technology via Yahoo Finance· 5 days agoMerck executive board chair and CEO Belén Garijo stated: “This strategic acquisition is a further...
Is Merck & Co., Inc. (NYSE:MRK) the Best Dow Stock To Buy According to Hedge Funds?
Insider Monkey via Yahoo Finance· 2 days agoWe recently identified the best dow stocks according to hedge funds. Even though Merck & Co., Inc....
McKesson, Merck back Atropos Health’s $33M round to accelerate drug development with AI
VentureBeat· 4 days agoAtropos Health, a healthcare technology company focused on generating personalized real-world...
Nvidia's split of soaring stock could boost retail investor appeal, Dow chances
Reuters via Yahoo News· 4 days agoNvidia shares were soaring 10% on Thursday afternoon after the company announced a 10-for-one stock...
TME Pharma Announces Convocation of the 2024 Annual General Meeting of Shareholders
Morningstar· 21 hours agoPharma N.V. (Euronext Growth Paris: ALTME) (Paris:ALTME),a biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), ...
ASCO 2024: Merus touts positive Phase II data for head and neck cancer antibody
Pharmaceutical Technology via Yahoo Finance· 4 days agoAmong abstracts announced yesterday by the American Society of Clinical Oncology (ASCO) is positive...
Bargain Bin: 3 Cheap Stocks to Buy Before Memorial Day
InvestorPlace· 4 days agoWall Street investors are looking for cheap stocks to buy before the summer holiday period. Despite...
Why Is Cancer-Focused Merus Stock Trading Over 30% On Friday?
Benzinga via Yahoo Finance· 3 days agoThursday, Merus N.V. (NASDAQ:MRUS) announced the publication of an abstract regarding petosemtamab...
Eisai Showcases Oncology Portfolio and Pipeline at ASCO 2024
FOX 23 News Albany· 5 days agoEisai announced today the presentation of research across multiple types of cancer from its oncology portfolio and pipeline during the 2024 American Society of Clinical...